miR-378a: a new emerging microRNA in metabolism

Cell Mol Life Sci. 2020 May;77(10):1947-1958. doi: 10.1007/s00018-019-03375-z. Epub 2019 Nov 20.

Abstract

Metabolic diseases, such as type 2 diabetes or obesity, are the consequence of the disruption of the organism's metabolic pathways. The discovery of small non-coding RNAs-microRNAs (miRNAs)-as post-transcriptional gene regulators opened new doors for the development of novel strategies to combat said diseases. The two strands of miR-378a, miR-378a-3p, and miR-378a-5p are encoded in the Ppargc1b gene and have an active role in the regulation of several metabolic pathways such as mitochondrial metabolism and autophagy. Recent studies recognized miR-378a as an important regulator of energy and glucose homeostasis, highlighting it as a potential target for the improvement of metabolic dysregulation. In the present review, the current knowledge on miR-378a will be discussed with a particular emphasis on its biological functions and mechanisms of action in metabolism, mitochondria, and autophagy.

Keywords: Autophagy; Metabolic diseases; Metabolism; Mitochondria; miR-378a.

Publication types

  • Review

MeSH terms

  • Autophagy / genetics
  • Cell Proliferation / genetics
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / metabolism
  • Gene Expression Regulation / genetics
  • Humans
  • Metabolic Diseases / genetics*
  • Metabolic Diseases / metabolism
  • Metabolic Networks and Pathways / genetics*
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Mitochondria / genetics*
  • Mitochondria / metabolism
  • Obesity / genetics
  • Obesity / metabolism
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism

Substances

  • MIRN378 microRNA, human
  • MicroRNAs
  • PPARGC1B protein, human
  • RNA-Binding Proteins